AI Infra
A Standalone AI Drug Discovery Validation Environment for Sensitive Bio Data | Samsung Bioepis
2026.04.30.
The use of generative AI—spanning AI drug discovery, omics analysis, and internal chatbots—is expanding rapidly across R&D in the biotech industry. But in environments that handle sensitive research data and clinical information, data security and rigorous validation are just as critical as the pace of AI adoption itself.
Conventional shared GPU server setups made it difficult for individual researchers and developers to run independent experiments on demand, or for teams to move quickly on department-level PoCs. Drug discovery and clinical data—where external exposure is strictly restricted—called for a dedicated, secure validation environment. To address these needs, the BIOEPIS AI Team at Samsung Bioepis adopted MonBox MAX, deploying a standalone AI development and validation system that R&D staff could use directly. The goal was to secure both rigorous data protection and experimental agility at the same time.
■ A Standalone, On-Premises Environment for Sensitive Data
In bio R&D, minimizing the risk of external data exposure is paramount. Research data, clinical information, and competitively sensitive material generated throughout the drug discovery process cannot be freely processed in public clouds or shared environments. MonBox provided an on-premises standalone AI development environment, enabling sensitive data to be handled securely inside the organization. This gave the research team a foundation for validating AI models and testing generative AI capabilities in parallel—without compromising data security requirements.
■ A Plug-and-Play AI Validation System for R&D Staff
When building a new AI development environment, the most time-consuming work is typically hardware provisioning and software configuration. Selecting GPU specifications, installing frameworks, setting up open-source packages, and verifying version compatibility all add up—delaying the point at which the environment becomes usable in real research. MonBox MAX ships pre-configured with the platforms and key open-source packages required for AI development, allowing it to go straight into validation work without complex infrastructure setup. Researchers and developers could focus on model validation, data analysis, and PoC execution rather than environment configuration.
■ Designed to Integrate with Existing Internal Validation Systems
Samsung Bioepis required a practical system that could flexibly integrate with its existing internal validation stack, built on SCP and LangSmith. AI infrastructure delivers real value not as a standalone box, but only when it connects naturally into the broader operational environment already in place. Backed by validated standard specifications and a pre-configured runtime environment, MonBox provided an AI development foundation designed with both department-level experimentation and integration with existing systems in mind. High-performance hardware configurations tailored to model scale helped reduce adoption risk while supporting validation of large-scale AI models.
The Samsung Bioepis case shows how MonBox can be deployed in bio R&D environments where protecting sensitive data is critical. Rather than functioning simply as a GPU compute appliance, MonBox served as a standalone AI development infrastructure—enabling R&D teams to rapidly carry out AI drug discovery and LLM agent validation within a secure internal environment.
